Xigran (drotrecogin alfa activated)

drotrecogin alfa activated · Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Xigran (drotrecogin alfa activated), covering 2016-08-31 to 2016-08-31. Get the full timeline:

Most recent: Clinical Trial Update: Modulation of Vasoreactivity in Septic Shock: Impact of Recombinant Protein C [Phase 4]